We are live on
!
Find out more
TC
TradeLink Capital Portfolio holdings
AUM
$13.2M
1-Year Est. Return
33.27%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+33.27%
3 Year Est. Return
+48.31%
5 Year Est. Return
+69.64%
10 Year Est. Return
+1,512.66%
AUM
$324M
AUM Growth
–
Cap. Flow
+$326M
Cap. Flow
% of AUM
100.66%
Top 10 Holdings %
Top 10 Hldgs %
45.83%
Holding
412
New
412
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$87.4M |
| 2 |
Zoetis
ZTS
|
+$25.4M |
| 3 |
ExxonMobil
XOM
|
+$8.97M |
| 4 |
IBM
IBM
|
+$5.99M |
| 5 |
Philip Morris
PM
|
+$4.64M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.29% |
| 2 | Technology | 9.61% |
| 3 | Consumer Discretionary | 7.79% |
| 4 | Energy | 7.21% |
| 5 | Industrials | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
W.W. Grainger
GWW
$66B
| $76K | 0.02% |
+300
| New | +$74.3K |
|
377
Progressive
PGR
$128B
| $76K | 0.02% |
+3,000
| New | +$75.8K |
|
|
PDCO
378
DELISTED
Patterson Companies, Inc.
PDCO
| $75K | 0.02% |
+2,000
| New | +$76.2K |
|
379
Edwards Lifesciences
EW
$48.2B
| $74K | 0.02% |
+6,600
| New | +$78.1K |
|
|
VTLE
380
DELISTED
Vital Energy
VTLE
| $74K | 0.02% |
+180
| New | +$66.5K |
|
381
Monster Beverage
MNST
$95.6B
| $73K | 0.02% |
+7,200
| New | +$67.6K |
|
382
Raymond James Financial
RJF
$34B
| $73K | 0.02% |
+2,550
| New | +$73.7K |
|
|
PRE
383
DELISTED
PARTNERRE LTD
PRE
| $72K | 0.02% |
+800
| New | +$72.8K |
|
|
SIAL
384
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $72K | 0.02% |
+900
| New | +$72.1K |
|
385
KeyCorp
KEY
$24.3B
| $71K | 0.02% |
+6,400
| New | +$65.8K |
|
386
McCormick & Company Non-Voting
MKC
$13.9B
| $70K | 0.02% |
+2,000
| New | +$72K |
|
387
Oneok
OKE
$55.9B
| $70K | 0.02% |
+1,942
| New | +$79.9K |
|
388
Range Resources
RRC
$8.94B
| $70K | 0.02% |
+900
| New | +$68.7K |
|
389
Analog Devices
ADI
$178B
| $68K | 0.02% |
+1,500
| New | +$67.5K |
|
390
FMC
FMC
$1.37B
| $67K | 0.02% |
+1,268
| New | +$66.9K |
|
|
PPLI
391
People Inc
PPLI
$3.13B
| $67K | 0.02% |
+7,834
| New | +$66.8K |
|
392
M&T Bank
MTB
$36.6B
| $67K | 0.02% |
+600
| New | +$61.8K |
|
|
QEP
393
DELISTED
QEP RESOURCES, INC.
QEP
| $67K | 0.02% |
+2,400
| New | +$69.7K |
|
394
Oceaneering
OII
$4.78B
| $65K | 0.02% |
+900
| New | +$62.8K |
|
395
Lazard
LAZ
$4.21B
| $64K | 0.02% |
+2,000
| New | +$66.9K |
|
396
Idexx Laboratories
IDXX
$44.9B
| $63K | 0.02% |
+1,400
| New | +$61.2K |
|
|
COL
397
DELISTED
Rockwell Collins
COL
| $63K | 0.02% |
+1,000
| New | +$63.8K |
|
398
Church & Dwight Co
CHD
$23.7B
| $62K | 0.02% |
+2,000
| New | +$62.5K |
|
399
Xylem
XYL
$29.2B
| $62K | 0.02% |
+2,300
| New | +$63.5K |
|
|
DNR
400
DELISTED
Denbury Resources, Inc.
DNR
| $62K | 0.02% |
+3,600
| New | +$64.6K |
|
Similar funds
PSFG
SCI
GBCP
IWM
DOFI
RC
M
AWGLSCP
TradeLink Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for TradeLink Capital, which disclosed 412 positions worth $324M. Its ten largest holdings account for 46% of the portfolio.
Its largest position is Pfizer: 3,162,000 shares worth $84M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, followed by Technology and Consumer Discretionary.
- TradeLink Capital's largest Q2 2013 buy was Pfizer: 3,162,000 shares worth $84M.
- TradeLink Capital's ten largest holdings make up 46% of its $324M portfolio in Q2 2013.
- TradeLink Capital disclosed 412 positions in Q2 2013, its first 13F filing on record.
Based on TradeLink Capital's 13F filing for Q2 2013, filed 31 Jul 2013.